News
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in treatment for cancers, rare disease and more.
New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual.
IO Biotech said on Monday its experimental combination vaccine for a type of skin cancer helped slow the disease's ...
Cylembio is a therapeutic cancer vaccine candidate that targets cells and immune-suppressive cells in the tumor microenvironment through activation and expansion of T cells against IDO1 and/or PD-L1 ...
Scientists have discovered the ability to “personalize” cancer treatments using cutting-edge genetic technology - but experts ...
Best Life on MSN1d
Colon Cancer Vaccine Gets One Step Closer to Reality
The "off-the-shelf" vaccine has also shown promising results for pancreatic cancer. Since the U.S. Preventive Services Task ...
The HPV campaign’s success in Sindh will depend not only on logistics but also on addressing deep-rooted social inequities. A ...
Researchers found patients with pancreatic cancer and bowel cancer survived more than two years after receiving the vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback